RFK Jr. Vaccine Advisors & Mercury Flu Shots
A newly appointed government panel, under Secretary Robert F. Kennedy Jr., will vote on the controversial use of thimerosal-a mercury-containing preservative-in flu shots. This advisory Committee on Immunization Practices (ACIP) meeting marks a pivotal first step for advisors who have raised vaccine skepticism,possibly reshaping the landscape of vaccine policy. The FDA maintains no link between thimerosal adn autism, but the ACIP’s immunization recommendations crucially shape U.S. policy.Understanding the committee’s role is paramount, influencing vaccine eligibility and insurance coverage.News Directory 3 provides real-time updates. Discover what’s next with this developing story.
Vaccine Advisory panel to Vote on Thimerosal Use in Flu Shots
A revamped government panel advising on vaccine policy, appointed by Health and Human Services Secretary Robert F. Kennedy Jr., is set to vote on the use of thimerosal, a preservative containing mercury, in some flu shots. The Advisory Committee on Immunization Practices, or ACIP, will discuss thimerosal at a meeting June 26 and vote on related recommendations.
The meeting marks the first for the newly appointed ACIP members, many of whom have voiced skepticism about vaccines. Kennedy appointed the eight advisors after dismissing the previous 17 members of the committee, which advises the Centers for Disease Control and Prevention on immunization matters.
While the specifics of the presentation and vote remain unclear, thimerosal has been used for decades to prevent bacterial growth in multi-dose vaccines. Its use has declined as single-dose packaging becomes more common.Some multi-dose flu vaccines, including SanofiS Fluzone and two CSL Seqirus shots, still contain thimerosal. The Food and Drug Administration says all vaccines routinely recommended for children 6 years and younger are available without thimerosal.
Despite past concerns, the FDA and other health organizations maintain that numerous studies have found no connection between thimerosal and autism.
“The scientific evidence collected over the past 20+ years does not show any evidence of harm, including serious neurodevelopmental disorders, from use of thimerosal in vaccines,” the FDA said on its website.
the ACIP’s recommendations play a notable role in shaping U.S. immunization policy, influencing vaccine eligibility and insurance coverage. The committee is also scheduled to review data and vote on vaccines for COVID-19 and RSV at the meeting.
What’s next
The ACIP’s upcoming vote on thimerosal will be closely watched, as it could signal a shift in the nation’s approach to vaccine policy and the use of preservatives in immunizations.